CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 340 participants.

Also called NCT05726526

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 340 participants (planned count) (from the registry)
Sponsor
University of Manitoba (from the registry)
Registry
  • NCT NCT05726526
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05726526. Randomized; single masking; primary purpose supportive care. Start 2022-06-30 (actual); primary completion 2027-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Acronym
VIEWER
Condition
Chronic Kidney Disease Stage 5
Condition
End Stage Renal Disease
Intervention (Device)
VIEWER virtual care platform
Lead sponsor
University of Manitoba (class: other)

Record details

Record id
cardio:ct-nct05726526
Content hash
cc1087ae99f30b2f401e38c51088af635db1f8ccd985ab0c7322b54cd4a5b8ac